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Abstract 
Introduction: Whole genome sequencing (WGS) has shown superiority over other bacterial typing methods and can be used to monitor disease 
transmission. The long culture period hinders use of WGS as a diagnostic tool for TB. The ideal situation would be to efficiently sequence 
directly from clinical specimens such as sputum. Attempts to sequence directly from Mtb clinical samples have achieved very low coverage 
(less than 0.7X). We compared DNA extraction methods for direct extraction from Mycobacterium tuberculosis positive sputum and assessed 
their suitability for Single Molecule Real Time sequencing. 
Methodology: We evaluated the extraction efficiency of the PrimeXtract kit and an in-house CTAB method by extracting DNA from Mtb 
sputum. We evaluated the methods on these parameters: ease of use, efficiency (quantity and purity) and the cost per extraction.  
Results: The PrimeXtract kit was able to isolate 5.93 µg/mL ± 0.94, (Mean ± SEM) concentration of DNA and a yield of 0.2975 µg ± 0.04723, 
(Mean ± SEM). Comparatively, the CTAB method isolated 1.88 µg/mL ± 0.38 DNA and a yield of 0.09 µg ± 0.02. Both concentration and 
yield from the kit were significantly (p = 0.0002) higher than those from CTAB. The PrimeXtract kit had a DNA purity ratio of 1.69 ± 0.09 
compared to the CTAB’s 1.73 ± 0.14 and this difference was not statistically different. 
Conclusion: PrimeXtract kit has a superior extraction efficiency than the CTAB method on Mtb sputum in terms of DNA yield although no 
significant difference by DNA purity was seen.  
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Introduction 
Tuberculosis (TB) is the ninth leading cause of 
mortality worldwide whose impact has been 
exacerbated by coinfection with HIV/AIDS. Most TB 
deaths could be prevented with early diagnosis and 
appropriately timed treatment [1]. The advent of high 
throughput DNA sequencing platforms has led to 
unprecedented use of whole genome sequencing 
(WGS) to better understand the genome and epigenome 
of Mycobacterium tuberculosis (Mtb) the causative 
agent for TB [2]. WGS has shown superiority over other 
bacterial typing methods and can be used to monitor 
disease transmission [3]. The long culture period 
hinders use of WGS as a diagnostic tool for TB [4]. The 
ideal situation would be to efficiently sequence directly 
from clinical specimens such as sputum.  
Attempts to sequence from Mtb clinical samples 
have achieved very low coverage (less than 0.7X) as a 
consequence of high human DNA contamination [4]. In 
the study, a NucleoSpin Tissue-Kit for hard to lyse 
bacteria was used [5]. Some DNA extraction methods 
including Infection Diagnostic Inc (IDI) lysis tubes, 
Prepman Ultra, Qiagen QIAamp, Tris-EDTA, Sodium 
dodecyl sulfate (SDS)-Triton X and Tris-EDTA (TE) 
buffer have been evaluated for direct extraction of Mtb 
sputum for polymerase chain reaction (PCR). The 
Cetyltrimethylammonium bromide (CTAB) method 
was found to be superior for direct extraction from 
sputum in a study of seven DNA extraction protocols 
[6] . The Primextract, a commercially available DNA 
extraction kit has shown great promise in the extraction 
of DNA directly from clinical samples [7]. 
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Single Molecule Real Time (SMRT) Sequencing 
yields highly accurate consensus sequences as it offers 
long read lengths and random error profiles [8]. 
Additionally, SMRT sequencing lacks GC bias and can 
be used to detect DNA base modifications [8]. 
However, unlike other sequencing technologies, SMRT 
sequencing has stringent DNA requirements. Pure high 
molecular weight double stranded native DNA is 
required as there is no amplification step during 
sequencing [9]. Some studies have sequenced Mtb 
DNA from commercial kits using SMRT sequencing 
but this has largely been from culture [2]. To date and 
to the best of our knowledge, no study has attempted 
SMRT sequencing directly on clinical samples either 
through a commercial kit or an in-house DNA 
extraction method. 
We hereby report an evaluation of a commercially 
available DNA extraction kit; Primextract kit 
(Longhorn Vaccines and Diagnostics, USA) and an in-
house Cetyltrimethylammonium bromide (CTAB) 
based method directly from confirmed Mtb positive 
sputum. The two methods were evaluated on the ease of 
use, efficiency (quantity and purity) and the cost per 




Samples and Bacteriological Methods 
Sputum samples were collected from a total of 120 
TB patients and frozen on the same day of collection 
under a different TB study. From these, a total of forty 
TB confirmed 3+ positive samples were selected for 
extraction. Mtb was confirmed by both BD MGIT TBC 
ID test device (Becton Dickinson, Maryland, U.S.A) 
following manufacturer’s instructions and Ziehl-
Neelsen staining. 
 Prior to processing all samples were kept frozen at 
-20°C. Samples were decontaminated with sodium 
hydroxide and N-acetly-l-l-cysteine (NaOH/NALC) 
with 1% NaOH final concentration. Following 
centrifugation each pellet was re-suspended in 1 mL of 
buffer and used for direct DNA extraction. Each sample 
was homogenized by vortexing at maximum speed for 
5 minutes. A 50 µL aliquot and three tenfold dilutions 
were drawn from each sample before the extraction and 
used to determine cell density. Colony forming units 
(CFU) were calculated using the formula:  
CFU = Number of colonies × 20 (50 µL was 
inoculated into each segment) × dilution factor 
 
Genomic DNA Isolation 
The Primextract DNA extraction kit (Longhorn 
Vaccines and Diagnostics, San Antonio, USA) was 
evaluated following manufacturer’s instructions. A 200 
µL aliquot of each decontaminated sample was 
processed according manufacturer’s protocol. As a 
positive control, a H37Rv loopful that had been re-
suspended in 200 µL molecular biology grade water 
was processed in a similar way for the kit. The 
Primextract kit is a spin-column based kit with ready to 
use lysis and wash solutions. It uses no heated 
incubation and has short centrifugation times. As a 
comparator the in-house CTAB method, samples were 
processed as previously described [6] with 
modifications. In brief to a 200 µL aliquot of the same 
sample where the kit sample was drawn, an equal 
amount of TE buffer was added and boiled at 85°C for 
10 minutes to kill the Mtb. This was followed by 
immediate freezing at -20°C for 15 minutes and 
addition of 40 µL (20mg/mL) lysozyme. Following 
incubation at 37°C for 1 hour, bacterial membrane was 
disrupted by increasing the temperature to 65°C. 
Proteinase K (250µg/mL final concentration) and 1% 
SDS were added with continuous agitation. This was 
followed by addition of 10% CTAB and 0.7 M to a 
combined final concentration of 1%. Following 
incubation at 65 °C for 20 minutes, DNA was extracted 
with chloroform:isoamyl alcohol (24:1) and 
precipitated using 0.6 volumes isopropanol. All DNA 
was eluted in 50 µL of elution solution/ Tris-EDTA 
(TE) buffer and concentrations were measured using 
Qubit 3.0 fluorometer (Life Technologies, Austin, 
USA) whereas DNA purity was determined using a 
NanoDrop Spectrophotometer (ND-1000, NanoDrop 
Technology, Wilmington, Delaware, USA). A 260/280 
ratio of 1.8-2.0 was considered to be high purity DNA. 




The efficiency of two DNA extraction methods for 
forty samples was compared. Prism 7.0 software 
(Graph Pad La Jolla, CA, USA) was used for statistical 
analysis of the data. Means of concentrations, yield and 
purity of DNA were calculated. The Welch corrected t-
test was used to test statistical significance of the data 
with a p value of < 0.05 indicating a significantly 
statistical difference between parameters being 
compared. 
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Results 
The study compared the efficiency of the two 
extraction methods. Ease of use, total time, DNA yields 
(µg), concentration (µg/mL) and purity obtained from 
extraction using two different methods were compared. 
Cell densities of samples used in the study were 
determined by plating a 50 µL aliquot and three tenfold 
dilutions for CFU calculation. Despite being positive 
for DNA, majority of samples had zero CFU counts as 
they could not be revived. These were recorded as < 80 
cfu/mL as this was the lowest recorded CFU count 
although we were mindful this DNA could as well be 
via host contamination. The kit uses a single sample 
preparation step with 5 centrifugation times of 60 
seconds each with a total working time of < 1 hour. 
Comparatively, CTAB uses several reaction steps and 
longer centrifugation steps, the longest lasting up to 15 
minutes. Furthermore, the CTAB method has a total 
working time of ~7 hours. 
DNA concentrations were determined using a qubit 
fluorometer and results were presented as Mean ± SEM 
for each method. The yield was calculated from the 
concentration in 50 µL of DNA sample. The yield was 
also presented as Mean ± SEM. Significant differences 
were observed in both the concentration and yield.  
DNA purity was determined on a Nanodrop and 
results were also presented as Mean ± SEM. Results 
from this study indicate that the PrimeXtract kit 
produced both higher yield and concentration (Table 1 
and Figures 1 and 2). The kit had a concentration of 5.93 
µg/mL ± 0.94, (Mean ± SEM) and DNA yield of 
0.2975µg ± 0.04723, n = 40 (Mean ± SEM). 
Comparatively, the CTAB method produced a 
concentration of 1.88 µg/mL ± 0.38, (Mean ± SEM) and 
DNA yield of 0.09 µg ± 0.02, (Mean ± SEM). Both 
concentration and yield from kit were significantly (p = 
0.0002) higher than those from CTAB. The 
PrimeXtract kit had a DNA purity (260/280) ratio of 
1.69 ± 0.09 (Mean ± SEM) compared to the CTAB’s 
1.73 ± 0.14, n = 40 (Mean ± SEM). The kit purity was 
lower than that from CTAB (Figure 3) although this 
result was not statistically significant (p = 0.76). Purity 
values for the CTAB method, however, were much 
closer to the target purity range of 1.8-20. 
 




Yield (µg) Purity 260/280 Cost/sample Total time 
 Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM 
PrimeXtract 5.93 ± 0.94 0.29 ± 0.047 1.69 ± 0.09 5.76 0.5 
CTAB 1.88 ± 0.38 0.09 ± 0.02 1.73 ± 0.14 0.39 7 
 
Figure 1. Comparison of Concentrations of DNA extracted 
using two different methods. 
DNA concentrations from two different extraction methods; the 
PrimeXtract kit (Longhorn Vaccines, USA) and an in- house CTAB 
method (n = 40). Concentration was measured using a qubit fluorometer 
(µg/mL). 
Figure 2. Comparison of Yields of DNA extracted using two 
different methods. 
Yields of DNA obtained using two different extraction methods: The 
PrimeXtract kit (Longhorn vaccines, USA) and an in-house method 
CTAB (n = 40). Yields were calculated from concentrations (µg/mL). 
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Discussion 
The success of molecular downstream application 
very much depends on the quality and quantity of the 
DNA. Choice of a DNA extraction method is critical to 
this success. Unlike other WGS technologies, the 
PrimeXtract kit has been highly recommended for 
recovery of high molecular weight quality DNA 
directly from Mycobacterium tuberculosis clinical 
specimens [7]. Since we had previously successfully 
sequenced Mtb from a solid culture using SMRT, we 
then wanted to investigate if we could sequence directly 
from clinical specimens. To do this we had to find a 
DNA extract method that could efficiently extract DNA 
for such a purpose.  
In the present work, we have demonstrated that the 
PrimeXtract DNA extraction kit is superior to the 
CTAB method for the isolation of Mtb genomic DNA 
in a 200 µL sputum sample in terms of yield. The kit 
was capable of recovering higher quantities DNA than 
the comparator in the 200 µL sample under 
consideration. The superiority of the kit is demonstrated 
in almost all samples (Figures. 1 and 2 and Table 1) 
where despite an equal input material, it has higher 
DNA output. The kit uses a specialized lysis solution 
and wash buffers and aid to release the DNA and wash 
off any cell impurities. These are critical in release and 
clean-up of DNA. Further the kit uses a spin column 
that in some ways limits the input material. The 
sensitivity of the kit is enhanced by a silica-based spin 
column that traps the DNA during centrifugation. The 
other advantage of the kit is that it is easy to use with 
short centrifugation times (60 seconds each) and total 
time ± 1 hour. In the present study the kit, however, was 
deemed unsuitable for SMRT sequencing. It could only 
recover less than 2 µg of DNA required for a 5Kb insert 
SMRTbell library preparation. Despite this observation, 
the kit was able to isolate high DNA yields compared to 
other kits within its range namely Qiagen (28.2 pg) and 
Prepman (30.4 pg) 
The CTAB method has been shown to recover 
higher yields of DNA with good purity from clinical 
samples compared to other in house methods [6]. This 
is the first study to compare this method against the 
PrimeXtract kit. In our hands, the CTAB was inferior in 
terms of yield. Some investigators have suggested that 
CTAB method is efficient for DNA extraction from 
solid Mtb cultures [10]. Successful isolation of Mtb 
DNA especially from clinical samples requires harsh 
treatment to weaken the cell wall. In this study we used 
heating and immediate freezing to disrupt connections 
holding lipid contents together. It is obvious that this 
did not work very well. One study proposed heating at 
100°C in an appropriate buffer to achieve the results 
[11]. It has been suggested that use of phenol and 
chloroform helps in improving the yield [12]. We 
avoided using phenol as residual phenol is incompatible 
with Pac bio library preparation. Chloroform aids in 
denaturation of proteins and formation of a separating 
layer between aqueous and organic phases [6]. From 
our experience, the protein removal and DNA 
precipitation steps were appropriate as we have 
successfully applied them before. We used isopropanol 
to selectively remove DNA leaving RNA and other 
impurities. We then used 70% ethanol to wash off any 
remaining impurities from the DNA.  
There were a lot of variations on the purity obtained 
from the samples using the two methods (Figure 3). 
This could be due the different samples containing 
varying amounts of impurities. The CTAB, however, 
had better mean purity value 1.73 which is closer to the 
required range of 1.8-2.0 compared to the kit’s 1.69 
which is much lower. As we did not use phenol, the 
lower 260/280 ratio would most likely indicate protein 
contamination. This is suggestive of the fact that the 
chloroform step did not work properly.  
In addition to being labour-intensive, the CTAB 
method has a higher sample turn over time (total time 
7± hours) as compared to the kit’s < 1 hour. The CTAB 
method, however, has the advantage of being flexible. 
It is possible to increase the cell density and 
successfully recover higher amounts of DNA. To 
Figure 3. Comparison of Purity of DNA extracted using two 
different methods. 
Purity of DNA obtained using two different extraction method. The 
PrimeXtract kit (Longhorn Vaccines, USA) and an in-house CTAB 
method (n = 40). Purity was obtained using an ND-1000 
Spectrophotometer Nanodrop. A 260/280 value of 1.8-2.0 was 
considered a pure preparation. Error bars represent standard error of the 
mean (SEM). 
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improve purity however a eukaryotic DNA, clean up 
step may be necessary. Another point to consider in the 
choice of an extraction method would be the cost. The 
PrimeXtract kit costs $5.76 per extraction [7]. 
Compared to other DNA extraction kits, $2.30 for 
Qiagen and $1.05 for Prepman [5], the PrimeXtract 
costs well over double as much as the other methods. 
Comparatively the CTAB method costs ~$0.39 per 
extraction [13]. Evidently the PrimeXtract despite 
being more efficient in terms of time, labour and 
quantity of DNA, is much more expensive than the 
CTAB method. We were unable to accurately quantify 
cell densities as most of our frozen strains could not be 
resuscitated for CFU counts. This is due to the fact that 
freezing kills some of the cells. 
 
Conclusion 
Our results suggest that the PrimeXtract kit is 
superior to the CTAB method for direct DNA extraction 
from Mtb sputum. With proper optimization such as 
additional sample decontamination and DNA 
purification steps, the PrimeXtract kit holds the 
potential to be used in direct extraction from sputum for 
the purpose of SMRT sequencing. We have previously 
sequenced cultured isolates using the CTAB method. If 
CTAB is to be used for direct extraction, a much high 
starting sample than one used in this study will be 
required. For resource-poor settings where kits are not 
readily available, CTAB remains the method of choice. 
Choice of an extraction method should ultimately be 
based on cost and ease of use. The study had some 
limitations. There is need for direct correlation between 
DNA yield and CFUs. In our case, it was not possible 
to accurately determine the CFUs. Additionally, the 
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